In The News

Brain Research Offers Hope for Understanding Autism

Despite vast differences in the genetic code across individuals and ethnicities, the human brain shows a "consistent molecular architecture," report researchers supported by the National Institutes of Health (NIH). The finding is from a pair of studies that have created databases revealing when and where genes turn on and off in multiple brain regions through development (Nature, 478: 519-23).

"Our study shows how 650,000 common genetic variations that make each of us a unique person may influence the ebb and flow of 24,000 genes in the most distinctly human part of our brain as we grow and age," explained Joel Kleinman, MD, PhD, of the National Institute of Mental Health (NIMH) Clinical Brain Disorders Branch. He and NIMH grantee Nenad Sestan, MD, PhD, of Yale University, led the sister studies.

"Having at our fingertips detailed information about when and where specific gene products are expressed in the brain brings new hope for understanding how this process can go awry in schizophrenia, autism and other brain disorders," said NIMH director Thomas Insel, MD.

Both studies measured messenger RNA transcripts, which carry the message from DNA to create proteins and differentiated brain tissue. Each gene can make several transcripts that are expressed in patterns influenced by a subset of the approximately 1.5 million DNA variations unique to each individual. This unique set of transcripts is called a transcriptome, a unique molecular signature that is a measure of the diverse functional potential in the brain.

Rapid gene expression during fetal development abruptly switches to much slower rates after birth that gradually decline and eventually level off in middle age, the studies found. These rates surge again as the brain ages in the last decades, mirroring rates seen in childhood and adolescence. The databases hold secrets to how the ever-changing messenger chemical systems, cells and development processes of the brain are related to gene expression patterns through development.

For example, if a particular version of a gene is implicated in a disorder, the new resources might reveal how that variation affects its expression over time and by brain region. By identifying even distant genes that may be turning on and off in sync, the databases may help researchers discover whole modules of genes involved in the illness. They also can reveal how variation in one gene influences another's expression.

Dr. Kleinman's team focused on how genetic variations are linked to the expression of transcripts across the lifespan in the prefrontal cortex, which controls insight, planning and judgment. They studied 269 postmortem, healthy human brains ranging in age from 2 weeks after conception to 80 years old, using 49,000 genetic probes. The database on prefrontal cortex gene expression alone totals more than 1 trillion pieces of information.

Among key findings in the prefrontal cortex is that individual genetic variations are profoundly linked to expression patterns. The most similarity across individuals is detected early in development and again as we approach the end of life.

Different types of related genes are expressed during prenatal development, infancy and childhood, so each stage shows a relatively distinct transcriptional identity. Three-fourths of genes reverse their direction of expression after birth, with most switching from on to off.

The expression of genes involved in cell division declines prenatally and in infancy, while the expression of genes important for making synapses increases. In contrast, genes required for neuronal projections decline after birth - likely as unused connections are pruned.

By the time we reach our 50s, overall gene expression begins to increase, mirroring the sharp reversal of fetal expression changes that occur in infancy.

Another highlight of this research is that genetic variation in the genome as a whole showed no effect on variation in the transcriptome as a whole, despite how genetically distant individuals might be. As a result, each human cortex has a consistent molecular architecture, despite our diversity.

Dr. Sestan and colleagues characterized gene expression in 16 brain regions, including 11 areas of the neocortex, from both hemispheres of 57 human brains that spanned from 40 days post-conception to 82 years. They analyzed the transcriptomes of 1,340 samples. Using 1.4 million probes, the researchers measured the expression of exons, which combine to form the protein product of a gene. This allowed them to pinpoint changes in these combinations that make up a protein, as well as to chart the overall expression of a gene.

Among the key findings is that more than 90 percent of the genes expressed in the brain are regulated differentially across brain regions and/or over developmental time periods. There are also widespread differences across region and time periods in the combination of the exons of a gene that are expressed.

Timing and location are far more influential in regulating gene expression than gender, ethnicity or individual variation, the researchers found.

Among 29 modules of co-expressed genes identified, each had distinct expression patterns and represented different biological processes. Genetic variation in some of the most well-connected genes in these modules, called hub genes, previously was linked to mental disorders, including schizophrenia and depression.

Telltale similarities in expression profiles with genes previously implicated in schizophrenia and autism are providing leads to discovery of other genes potentially involved in those disorders.

Gender differences in the risk for certain mental disorders may be traceable to transcriptional mechanisms. More than three-fourths of 159 genes expressed differentially between the sexes were male-biased, most prenatally. Some genes found to have such gender-biased expression previously were associated with disorders that affect males more than females, such as schizophrenia, Williams syndrome and autism.

This study also was funded by the National Institute on Child Health and Human Development, National Institute on Neurological Disorders and Stroke, and National Institute on Drug Abuse. Data for the study are posted at and as part of a larger ongoing study, BrainSpan, which is funded by NIMH under the American Recovery and Reinvestment Act to create an Atlas of Human Brain Development (

The data on genetic variability in Dr. Kleinman's study are accessible to researchers at The gene expression data can be found at BrainCloud, a Web browser application developed by NIMH to interrogate the study data, can be downloaded at

In The News Archives


Email: *

Email, first name, comment and security code are required fields; all other fields are optional. With the exception of email, any information you provide will be displayed with your comment.

First * Last
Title Field Facility
City State

Comments: *
To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the below image, reload the page to generate a new one.

Enter the security code below: *

Fields marked with an * are required.

View the Latest from ADVANCE


Search Jobs


Back to Top

© 2017 Merion Matters

660 American Avenue Suite 300, King of Prussia PA 19406